May 2, 2018
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Ada D. Sarmento
Ms. Erin Jaskot
Re: | InflaRx N.V. Registration Statement on Form F-1 (SEC File No. 333-224596) |
Dear Ms. Sarmento and Ms. Jaskot:
In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of InflaRx N.V. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern time, on May 3, 2018 or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that we have distributed 1,020 copies of the Preliminary Prospectus dated May 2, 2018 (the “Preliminary Prospectus”) through the date hereof, to underwriters, dealers, institutions and others.
(Signature page follows)
J.P. MORGAN SECURITIES LLC
LEERINK PARTNERS LLC
BMO CAPITAL MARKETS CORP.
For themselves and as representatives of the syndicate of
underwriters for the offering
J.P. MORGAN SECURITIES LLC
By: | /s/ David Ke |
Authorized Signatory |
LEERINK PARTNERS LLC
By: | /s/ Jack Fitzgerald |
Authorized Signatory |
BMO CAPITAL MARKETS CORP.
By: | /s/ Mihir Mantri |
Authorized Signatory |